Figure 6
From: Alternative TFAP2A isoforms have distinct activities in breast cancer
AP-2α isoforms exert different levels of transactivation activity at the ERBB2 promoter. HepG2 cells were transfected with 0.12 μg/well p500 ErbB2-luc, 0.02 μg/well renilla hRG, 0.06 μg/well pCI-p300, 0.06 μg/well pcDNA3-CITED2, and indicated ratios (corresponding to a total of 0.06, 0.12, 0.24 and 0.48 μg/well) of the different pcDNA3-AP-2α constructs. The average and standard error of three independent experiments is represented.